Status:
UNKNOWN
Impact of TAVI on Cognition, Mood and Health-related Quality of Life
Lead Sponsor:
Medical University of Graz
Conditions:
Cognitive Impairment
Eligibility:
All Genders
19-90 years
Brief Summary
In the proposed study, patients with and without embolic protection devices during Transcatheter Aortic Valve Implantation will be repeatedly examined with a comprehensive psychiatric and cognitive te...
Detailed Description
The percutaneous aortic valve replacement (TAVI, Transcatheter Aortic Valve Implantation) enables the implantation of a new biological aortic valve at the beating heart. The procedure is performed und...
Eligibility Criteria
Inclusion
- Written declaration of consent of the study participants to participate in the study after detailed information on the nature, significance, risks and scope of the study.
- Women and men between the ages of 19 and 90
- Clinical indication for TAVI intervention
- No previous psychiatric illness before TAVI
- No other serious disease affecting the immune system
Exclusion
- Non-compliance with the inclusion criteria
- Persons unable to give consent (e.g. dementia, delirium etc.)
- Magnetic resonance imaging (MR) contraindications
- ophthalmological inability to read
Key Trial Info
Start Date :
February 20 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 29 2025
Estimated Enrollment :
128 Patients enrolled
Trial Details
Trial ID
NCT04371172
Start Date
February 20 2023
End Date
May 29 2025
Last Update
January 11 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Medical University of Graz
Graz, Styria, Austria, 8036